The Wiskott-Aldrich Syndrome Protein-interacting Protein (WIP) Binds to the Adaptor Protein Nck*

Inés M. AntónDagger §, Wange Lu, Bruce J. Mayer, Narayanaswamy RameshDagger , and Raif S. GehaDagger parallel

From the Division of Dagger  Immunology and  Howard Hughes Medical Institute, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Nck is a ubiquitous adaptor molecule composed of three Src homology 3 (SH3) domains followed by a single SH2 domain. Nck links, via its SH2 domain, tyrosine-phosphorylated receptors to effector proteins that contain SH3-binding proline-rich sequences. In this report, we demonstrate that recombinant Nck precipitates endogenous WIP, a novel proline-rich protein that interacts with the Wiskott-Aldrich syndrome protein (WASP), from BJAB cell lysates. Nck binds through its second SH3 domain to WIP, and Nck binds to WIP at a site (amino acids 321-415) that differs from the WASP-binding site (amino acids 416-488). WIP has been shown to associate with the actin polymerization regulatory protein profilin and to induce actin polymerization and cytoskeletal reorganization in lymphoid cells. We demonstrate the presence of profilin in Nck precipitates suggesting that Nck may couple extracellular signals to the cytoskeleton via its interaction with WIP and profilin.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Nck is a 47-kDa protein ubiquitously expressed in mammalian cells (1) and is composed of three tandem Src homology 3 (SH3)1 domains followed by a single SH2 domain. Nck has no intrinsic catalytic activity and acts as an adaptor molecule to couple upstream signals, usually those initiated by activation of receptor tyrosine kinases (RTKs), to downstream signal transducer molecules.

Ligand binding to RTK induces the receptor chains to dimerize and to transphosphorylate on specific tyrosine residues that provide docking sites for SH2 domains (2). Nck interacts via its SH2 domain with phosphotyrosine residues in RTKs such as the receptors for epidermal growth factor, platelet-derived growth factor, vascular endothelial cell growth factor, and ephrin receptors (EphB1 and EphB2) (3-7) or in protein substrates of RTKs such as insulin receptor substrate-1 (8). Nck interacts via its SH3 domains with effector molecules containing proline-rich sequences bringing them to the proximity of ligandactivated RTKs.

The three SH3 domains (SH3.1, SH3.2, and SH3.3) of Nck interact selectively with target proteins. The SH3.1 domain mediates Nck association with the Nck-associated protein 1 (Nap1) (9). The SH3.2 domain mediates Nck interaction with p21-associated kinase (10, 11), Sos, a guanine nucleotide exchange factor for Ras (12), the serine/threonine kinase PRK2/NAK (13, 14), and Nck, Ash-, and phospholipase Cgamma -binding protein 4 (15). The SH3.3 domain mediates Nck interaction with the Wiskott-Aldrich syndrome protein (WASP) (16), and the gamma  isoform of the serine/threonine kinase casein kinase I (CKI-gamma 2) (17). Other proteins that have been shown to interact with Nck but for which the specific SH3 domain that mediates binding has not been defined include c-Cbl (18), focal adhesion kinase (19), pp105, a lymphocyte-type CRK-associated substrate that binds to FAK and Crk (20), and Nck interacting kinase (21). Recently a nuclear protein, SAM 68, has been identified as a specific binding partner of nuclear Nck (22). The SH3 domains of Dock, the Drosophila homologue of Nck, have been shown to interact with the Drosophila protein-tyrosine-phosphatase dPTP61F (23).

Cytoskeletal rearrangement is triggered by a variety of external stimuli such as growth factors, stress, and adhesion through integrins (24) and is mediated by small GTPases. In mammalian cells, Rho family GTPases control the reorganization of the actin cytoskeleton in response to growth factors. For example, epidermal growth factor and platelet-derived growth factor activate Rac which induces ruffling of the cell membrane with lamellipodia formation (24). Polymerization of actin filaments in the cytosol is orchestrated by secondary messengers of signal transduction pathways and by proteins that interact with actin. Profilin is a 15-kDa G-actin-binding protein that regulates actin filament assembly. Profilin promotes actin polymerization by favoring the exchange of ADP to ATP on actin (25) and by lowering the critical concentration of ATP-actin (26). Profilin can also contribute to the pool of unassembled actin when barbed ends are capped (27).

Recently, we have identified a novel WASP-interacting protein (WIP) (28). WIP is a widely expressed 503-amino acid long protein with homology in its amino-terminal sequence to the yeast protein verprolin which is involved in cytoskeleton organization (29). WIP overexpression increases the basal level of polymerized actin in human lymphoid cells and induces the formation of actin-rich cerebriform projections on the cell surface (28). WIP is proline-rich and contains potential SH3 domain-binding sequences. In an effort to investigate the role of WIP in signal transduction, we analyzed WIP binding to Nck. Our results show that Nck binds to WIP and suggest that WIP-Nck interaction may bridge cell-surface receptors to the actin cytoskeleton.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Yeast Two-hybrid System-- Full-length Nck cDNA was cloned in-frame into the bait vector pGBT9 (CLONTECH). The sequence of the clone was confirmed by DNA sequence analysis, and the clone was designated Nck-GBT9.

WIP4 is a truncation of WIP cDNA that encodes the carboxyl-terminal portion of WIP (amino acids 321-503) (28). WIP4 cDNA cloned in the yeast two-hybrid vector pGAD was used to construct the WIP4 deletion mutants. Deletions were obtained by digestion with the appropriate restriction enzymes followed by Klenow treatment and religation. pGAD-WIP-(321-415) was obtained by digestion with StuI and PstI, and pGAD-WIP-(321-376) was obtained by digestion with SfiI and PstI, and pGAD-WIP-(377-503) was obtained by SfiI digestion, Klenow treatment, EcoRI digestion, and a second Klenow treatment. WIP inserts for pGAD-WIP-(416-503) and pGAD-WIP-(416-488) constructs were obtained by polymerase chain reaction. All constructs were confirmed by sequencing.

Yeast transformation and colony analysis were performed according to the manufacturer's instructions (Matchmaker Two-Hybrid System Protocol, CLONTECH).

GST Fusion Proteins-- Glutathione S-transferase (GST) fusion proteins of Nck and of each of its three SH3 domains were generated as described previously (11). All expression constructs were verified by DNA sequence analysis. Expression of fusion proteins in transformed Escherichia coli was induced for 2 h with 0.1 mM isopropyl-thiobeta -D-galactopyranoside. Fusion proteins were purified as described previously (28).

Generation of WIP Expressing BJAB Cells-- WIP4 cDNA was cloned into a modified pcDNA3 vector that expresses cloned cDNA as an amino-terminal FLAG fusion protein and was transfected into the human B lymphoma cell line BJAB as described (28). The culture medium for BJAB-transfected cells was supplemented with 1.5 mg/ml G418 (Calbiochem).

Affinity Precipitation of WIP by GST Fusion Proteins-- Lysates of BJAB cells transfected with pcDNA3 or with pcDNA-WIP4 were obtained as described previously (28) and precleared for 1 h with 25 µl of GST-Sepharose (Amersham Pharmacia Biotech). Supernatants were tumbled for 16 h with 2 µg of GST or GST fusion proteins immobilized on GSH beads. The beads were washed, suspended in Laemmli loading buffer and subjected to PAGE on 4-15% gradient gels and Western blotting. The blots were developed with rabbit anti-WIP followed by protein A conjugated to horseradish peroxidase or with anti-FLAG M2 mAb followed by goat anti-mouse conjugated to horseradish peroxidase and enhanced chemiluminescent detection (ECL).

Immunoprecipitation of FLAG-WIP from BJAB Cells-- BJAB cells or BJAB cells transfected with pcDNA-WIP were washed twice with phosphate-buffered saline and lysed (45 × 106 cells in 0.35 ml) in ice-cold lysis buffer (50 mM Tris, pH 7.4, containing 150 mM NaCl, 5 mM MgCl2, 30% glycerol, 0.4 mM Na3VO4, 10 mM NaF, 10 mM Na3P2O7, protease inhibitor mixture (Complete, Boehringer Mannheim) and 1% Brij 96) for 30 min. Lysates were centrifuged at 16,000 × g for 15 min at 4 °C and precleared for 1 h at 4 °C with 5 µl of normal mouse serum bound to protein G-Sepharose (Amersham Pharmacia Biotech) and then incubated overnight at 4 °C with 8 µg of anti-FLAG M2 monoclonal antibody (mAb) or of isotype-matched control MOPC21 mAb preadsorbed onto 40 µl of protein G-Sepharose. The precipitates were washed 4× with modified lysis buffer containing 10% glycerol and 0.2% Brij-96, eluted in Laemmli loading buffer, and subjected to SDS-PAGE on 4-15% gradient gels and Western blot analysis with anti-FLAG mAb or anti-Nck mAb (Transduction Laboratories). The blots were developed by ECL as described above.

    RESULTS AND DISCUSSION
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Nck Interacts with WIP in the Yeast Two-hybrid System-- WIP contains several proline-rich sequences including three repeats of the sequence GRSGPXPPXP. This sequence is repeated twice in WASP and is involved in the binding of WASP to the SH3.3 domain of Nck (30). We therefore reasoned that WIP may be a candidate for binding to Nck. Since all the three GRSGPXPPXP sequences were present within WIP4, a truncation of WIP that contains amino acids 321-503, we tested the interaction of WIP4 with Nck by the yeast two-hybrid system. Table I shows that Nck interacts specifically with WIP4. Nck did not interact with human TRAF1 (tumor necrosis factor receptor-associated factor 1) used as a control, and WIP4 did not interact with laminin (Table I). As expected, WIP4 interacted with WASP (28).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Interaction of Nck and WIP by the yeast two-hybrid system
Two-hybrid assay results for HF7c clones containing the Gal 4 binding (pGBT9) or activation (pGAD424) domain vectors with the indicated fusion protein insert are shown. WIP4 represents amino acids 321-503 of WIP. TRAF1 represents amino acids 62-416 of human TRAF1. A - indicates no growth on Leu/Trp/His negative SD synthetic medium in the presence of 20 mM 3-aminotriazole. A ++ denotes growth both on the selective medium and beta -galactosidase activity with color development in 2 h, and +++ indicates growth on the selective medium and color change in 30 min. ND, not done.

Endogenous Nck Co-immunoprecipitates with WIP from BJAB Cells-- To demonstrate the Nck-WIP association in vivo, we examined whether Nck and WIP co-immunoprecipitate from cells. To this purpose, we examined the presence of Nck in anti-FLAG immunoprecipitates of lysates from human B cells BJAB transfected with FLAG-tagged WIP4 cloned in pcDNA3. Fig. 1 shows the presence of Nck in anti-FLAG immunoprecipitates from FLAG-WIP4 transfected cells (lane 1). Nck was not detected in MOPC21 mAb immunoprecipitates of WIP4-transfected cells (lane 2) nor in M2 immunoprecipitates of untransfected BJAB cells (lane 3). To ascertain the presence of FLAG-tagged WIP in the immunoprecipitates, the membrane was stripped and reblotted with anti-FLAG M2 mAb (Fig. 1, lower panel). FLAG-tagged WIP4 is detected in M2 immunoprecipitates from BJAB cells transfected with FLAG-WIP4 (lane 1) and, as expected, in total lysates from FLAG-WIP4-transfected cells (lane 4). FLAG-WIP4 was neither detected in MOPC21 immunoprecipitates from WIP4-transfected cells (lane 2) nor in M2 immunoprecipitates from untransfected cells (lane 3). Treatment of cells with phorbol 12-myristate 13-acetate for 15, 30, or 60 min did not alter the capacity of Nck and WIP to co-immunoprecipitate (data not shown) suggesting that Nck phosphorylation induced by phorbol 12-myristate 13-acetate (31) does not regulate WIP-Nck interaction.


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 1.   In vivo binding of endogenous Nck to WIP. FLAG-tagged WIP4 construct was transfected into human BJAB cells, and cell lysates were immunoprecipitated with anti-FLAG M2 antibody (alpha F, lane 1) or control MOPC 21 mAb (Ctr, lane 2). The immunoprecipitates were Western-blotted with anti-Nck mAb (upper panel) or anti-FLAG M2 (lower panel) followed by horseradish peroxidase-conjugated goat anti-mouse and then developed with ECL immunoblotting detection system. As additional controls, total lysates of WIP4-transfected BJAB cells (lane 4) and anti-FLAG immunoprecipitates from untransfected BJAB cells (lane 3) were Western-blotted with anti-Nck antibody or M2 antibody. The heavy (denoted by *) and light (bullet ) chains of the immunoprecipitating mAb are visualized because goat anti-mouse antibody was used as the second antibody in developing the Western blots. MOPC 21 heavy chain showed faster mobility in SDS-PAGE than M2 heavy chain.

WIP Binds to the Second SH3 Domain of Nck-- To confirm Nck interaction with full-length WIP, we used GST-Nck fusion protein to affinity precipitate endogenous WIP from BJAB cells. The precipitates were run on SDS-PAGE and Western-blotted with anti-WIP rabbit antibody. Fig. 2A shows that WIP is present in GST-Nck precipitates but not in control GST precipitates.


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 2.   Binding of endogenous WIP to GST-Nck and interaction of FLAG-tagged WIP4 polypeptide with Nck and Nck SH3 domains. A, lysates of BJAB cells were precleared by incubation with GST-Sepharose beads and incubated with glutathione-Sepharose-bound GST-Nck. The precipitates were washed and resolved by 4-15% gradient SDS-PAGE, immunoblotted with rabbit anti-WIP antibody, and the blots were developed by ECL as described in Fig. 1. B, lysates of BJAB cells transfected with FLAG-WIP4 were precleared by incubation with GST-Sepharose beads and incubated with glutathione-Sepharose bound GST fusion proteins of Nck and of individual Nck SH3 domains (SH3.1, SH3.2, and SH3.3). The precipitates were washed and resolved by 4-15% gradient SDS-PAGE and immunoblotted with anti-FLAG M2, and the blots were developed by ECL as described in Fig. 1. C, Coomassie Blue staining of the samples described in (B). The dots highlight the GST fusion proteins.

Since proteins that bind to Nck have a preference for one of its three SH3 domains, we sought to determine which of the three SH3 domains of Nck preferentially interacts with WIP. GST fusion proteins of Nck and of each of its individual SH3 domains were used to affinity precipitate WIP from BJAB cells transfected with FLAG-tagged WIP4 or with empty pcDNA3 vector, and the precipitates were run on SDS-PAGE and Western-blotted with anti-FLAG M2 antibody. Fig. 2B shows that WIP binds to the SH3.2 domain of Nck but not to the SH3.1 and SH3.3 domains of Nck. No bands were detected in precipitates of lysates from BJAB cells transfected with empty vector (data not shown). With longer exposures, we were able to detect WIP binding to SH3.1 and SH3.3 domains of Nck but not to GST (data not shown). As a control for fusion protein loading, we stained the gels with Coomassie Blue (Fig. 2C). The small differences in the amounts of fusion protein used (<2-fold) are unlikely to account for the difference in the ability of the Nck SH3 domains to bind WIP.

Two copies of the sequence GRSGPXPPXP which has been implicated in the binding of WASP to SH3.3 of Nck are present in the shortest truncation of WIP that binds Nck (WIP-(321-415)). Yet WIP bound poorly to SH3.3 of Nck. This suggests that residues other than those in the above sequence determine binding to individual SH3 domains of Nck. The SH3.3 domain of Nck mediates its binding to the serine/threonine kinase CKI-gamma 2 (17). It would be important to determine if WIP, which binds to the SH3.2 of Nck, is a potential target for phosphorylation by CKI-gamma 2.

Mapping of the Nck-binding Site of WIP-- We have previously shown that WASP binds to the carboxyl-terminal region of WIP, amino acids 377-503 (28). To determine whether the WASP- and Nck-binding sites on WIP overlap, we examined the interaction of WIP deletion mutants with WASP and Nck using the yeast two-hybrid system. Fig. 3 shows that WIP-(416-488) binds to WASP but not to Nck. In contrast, the WIP deletion mutant WIP-(321-415) binds to Nck but not to WASP. Taken together, these results show that the WASP and Nck binding domains of WIP differ.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 3.   Mapping of the Nck-binding site of WIP by two-hybrid system analysis. WIP4 deletion mutants were constructed in pGAD424, and their interaction with Nck-GBT9 was tested in yeast Saccharomyces cerevisiae strain HF7c. Numbers represent amino acid positions of the WIP sequence. A minus sign indicates no growth on Leu/Trp/His-negative SD medium in the presence of 20 mM 3-aminotriazole, and + denotes both growth on the selective medium and beta -galactosidase activity (+, color change in 4 h; ++, color change in 2 h; +++, color change in 30 min).

Since WIP and WASP bind preferentially to distinct SH3 domains of Nck, Nck may simultaneously engage WIP and WASP, thereby increasing the local concentration of both proteins and enhancing their interaction. Since different domains of Nck bind to WIP and WASP, different sites on WASP bind to WIP and Nck, and different sites on WIP bind to Nck and WASP; trimolecular complexes of Nck, WIP, and WASP may exist in which each of the proteins could contact the two others. Because each of WIP, WASP, and Nck has non-overlapping binding sites for the other two proteins, formal demonstration of a trimolecular complex of the three full-length proteins is not possible.

WIP May Bridge Nck to Profilin and the Cytoskeleton-- WIP interacts with profilin (28). The two profilin binding consensus sequences in WIP (APPPPP) are located at positions 8-13 and 427-432 and are outside the Nck-binding site (amino acids 321-415). This raised the possibility that WIP may couple Nck to profilin. We therefore examined whether profilin co-precipitates with Nck. Fig. 4 shows that endogenous profilin from lysates of BJAB cells is bound to GST-Nck but not to GST. Nck lacks proline-rich sequences, including profilin binding consensus sequences (A, G, L, or S followed by PPPPP) (32) and fails to interact with profilin in the yeast two-hybrid system (data not shown). These results suggest that the binding of profilin to Nck is indirect and may be mediated by WIP, although we cannot rule out a role for other intermediaries.


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 4.   Interaction of Nck and profilin. BJAB cell lysates were precleared by incubation with GST-Sepharose beads and incubated with glutathione-Sepharose-bound GST or GST fusion protein of Nck. The precipitates were washed and resolved by 4-15% gradient SDS-PAGE, immunoblotted with rabbit polyclonal anti-profilin followed by horseradish peroxidase-labeled protein A, and then developed by ECL system detection.

The Drosophila homologue of Nck, Dock, has been shown to be involved in the photoreceptor cell (R cell) axon guidance, suggesting that it plays a role in cytoskeletal reorganization (33). In addition to binding profilin, WIP contains the actin-binding KLKK sequence, and its overexpression increases the cell content of F-actin. Furthermore, via its interaction with WASP (28) and N-WASP,2 WIP may modulate cytoskeletal reorganization. Therefore, WIP may link Nck to the actin cytoskeleton. Since Nck is recruited to RTKs following their tyrosine phosphorylation subsequent to ligand binding, the Nck-WIP interaction we describe may provide an important link between extracellular signaling via RTKs and reorganization of the cytoskeleton.

    ACKNOWLEDGEMENT

We thank Dr. Erdyni Tsitsikov for the TRAF1-pGAD424 construct.

    FOOTNOTES

* This work was supported in part by National Institutes of Health Grants HL-59561-01 and AI-37130 (to N. R.) and by grants from the Baxter, Olsten, and Alpha Therapeutics Corp.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported by a fellowship from Fundación Ramón Areces, Madrid, Spain.

parallel To whom correspondence should be addressed: Enders 8, Division of Immunology, 300 Longwood Ave., Children's Hospital, Boston, MA 02115. Tel.: 617-355-7602; Fax: 617-355-8205; E-mail: geha{at}a1.tch.harvard.edu.

The abbreviations used are: SH3, Src homology 3; WASP, Wiskott-Aldrich syndrome protein; WIP, WASP-interacting protein; RTK, receptor tyrosine kinase; GST, glutathione S-transferasemAb, monoclonal antibodyPAGE, polyacrylamide gel electrophoresisECL, enhanced chemiluminescent detection.

2 N. M. Quiles, I. M. Antón, N. Ramesh, and R. S. Geha, unpublished results.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results & Discussion
References

  1. Lehmann, J. M., Riethmuller, G., and Johnson, J. P. (1990) Nucleic Acids Res. 18, 1048[Medline] [Order article via Infotrieve]
  2. Marshall, C. J. (1995) Cell 80, 179-185[Medline] [Order article via Infotrieve]
  3. Chou, M. M., Fajardo, J. E., and Hanafusa, H. (1992) Mol. Cell. Biol. 12, 5834-5842[Abstract]
  4. Li, W., Hu, P., Skolnik, E. Y., Ullrich, A., and Schlessinger, J. (1992) Mol. Cell. Biol. 12, 5824-5833[Abstract]
  5. Meisenhelder, J., and Hunter, T. (1992) Mol. Cell. Biol. 12, 5843-5856[Abstract]
  6. Stein, E., Huynh-Do, U., Lane, A. A., Cerrito, D. P., and Daniel, T. O. (1998) J. Biol. Chem. 273, 1303-1308[Abstract/Free Full Text]
  7. Holland, S. J., Gale, N. W., Gist, G. D., Wroth, R. A., Singeing, Z., Cantle, L. C., Henkemeyer, M., Yancopoulos, G. D., and Pawson, T. (1997) EMBO J. 16, 3877-3888[Abstract/Free Full Text]
  8. Lee, C.-H., Li, W., Nishimura, R., Zhou, M., Batzer, A. G., Myers, M. G., White, M. F., Schlessinger, J., and Skolnik, E. Y. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 11713-11717[Abstract]
  9. Kitamura, T., Kitamura, Y., Yonezawa, K., Totty, N. F., Gout, I., Hara, K., Waterfield, M. D., Sakaue, M., Ogawa, W., and Kasuga, M. (1996) Biochem. Biophys. Res. Commun. 219, 509-514[CrossRef][Medline] [Order article via Infotrieve]
  10. Galisteo, M. L., Chernoff, J., Su, Y., Skolnik, E. Y., and Schlessinger, J. (1996) J. Biol. Chem. 271, 20997-21000[Abstract/Free Full Text]
  11. Lu, W., Katz, S., Gupta, R., and Mayer, B. (1997) Curr. Biol. 7, 85-93[Medline] [Order article via Infotrieve]
  12. Hu, Q., Milfay, D., and Williams, L. T. (1995) Mol. Cell. Biol. 15, 1169-1174[Abstract]
  13. Quilliam, L. A., Lambert, Q. T., Mickelson-Young, L. A., Westwick, J. K., Sparks, A. B., Kay, B. K., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., and Der, C. J. (1996) J. Biol. Chem. 271, 28772-28776[Abstract/Free Full Text]
  14. Chou, M. M., and Hanafusa, H. (1995) J. Biol. Chem. 270, 7359-7364[Abstract/Free Full Text]
  15. Matuoka, K., Miki, H., Takahashi, K., and Takenawa, T. (1997) Biochem. Biophys. Res. Commun. 239, 488-492[CrossRef][Medline] [Order article via Infotrieve]
  16. Rivero-Lezcano, O. M., Marcilla, A., Sameshima, J. H., and Robbins, K. C. (1995) Mol. Cell. Biol. 15, 5725-5731[Abstract]
  17. Lussier, G., and Larose, L. (1997) J. Biol. Chem. 272, 2688-2694[Abstract/Free Full Text]
  18. Rivero-Lezcano, O. M., Sameshima, J. H., Marcilla, A., and Robbins, K. C. (1994) J. Biol. Chem. 269, 17363-17366[Abstract/Free Full Text]
  19. Choudhury, G. G., Marra, F., and Abboud, H. E. (1996) Am. J. Physiol. 270, F295-F300[Abstract/Free Full Text]
  20. Minegishi, M., Tachibana, K., Sato, T., Iwata, S., Nojima, Y., and Morimoto, C. (1996) J. Exp. Med. 184, 1365-1375[Abstract]
  21. Su, Y. C., Han, J., Xu, S., Cobb, M., and Skolnik, E. Y. (1997) EMBO J. 16, 1279-1290[Abstract/Free Full Text]
  22. Lawe, D. C., Hahn, C., and Wong, A. J. (1997) Oncogene 14, 223-231[CrossRef][Medline] [Order article via Infotrieve]
  23. Clemens, J. C., Ursuliak, Z., Clemens, K. K., Price, J. V., and Dixon, J. E. (1996) J. Biol. Chem. 271, 17002-17005[Abstract/Free Full Text]
  24. Zigmond, S. H. (1996) Curr. Opin. Cell Biol. 8, 66-73[CrossRef][Medline] [Order article via Infotrieve]
  25. Goldschmidt-Clermont, P. J., Furman, M. I., Wachsstock, D., Safer, D., Nachmias, V. T., and Pollard, T. D. (1992) Mol. Biol. Cell 3, 1015-1024[Abstract]
  26. Pantaloni, D., and Carlier, M.-F. (1993) Cell 75, 1007-1014[Medline] [Order article via Infotrieve]
  27. Perelroizen, I., Didry, D., Christensen, H., Chua, N., and Carlier, M. (1996) J. Biol. Chem. 271, 12302-12309[Abstract/Free Full Text]
  28. Ramesh, N., Anton, I. M., Hartwig, J. H., and Geha, R. S. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 14671-14676[Abstract/Free Full Text]
  29. Donnelly, S. F., Pocklington, M. J., Pallotta, D., and Orr, E. (1993) Mol. Microbiol. 10, 585-596[Medline] [Order article via Infotrieve]
  30. Finan, P. M., Soames, C. J., Wilson, L., Nelson, D. L., Stewart, D. M., Truong, O., Hsuan, J. J., and Kellie, S. (1996) J. Biol. Chem. 271, 26291-26295[Abstract/Free Full Text]
  31. Park, D., and Rhee, S. G. (1992) Mol. Cell. Biol. 12, 5816-5823[Abstract]
  32. Purich, D. L., and Southwick, F. S. (1997) Biochem. Biophys. Res. Commun. 231, 686-691[CrossRef][Medline] [Order article via Infotrieve]
  33. Garrity, P. A., Rao, Y., Salecker, I., McGlade, J., Pawson, T., and Zipursky, S. L. (1996) Cell 85, 639-650[Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.